[go: up one dir, main page]

AU2003203233A1 - N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same - Google Patents

N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same

Info

Publication number
AU2003203233A1
AU2003203233A1 AU2003203233A AU2003203233A AU2003203233A1 AU 2003203233 A1 AU2003203233 A1 AU 2003203233A1 AU 2003203233 A AU2003203233 A AU 2003203233A AU 2003203233 A AU2003203233 A AU 2003203233A AU 2003203233 A1 AU2003203233 A1 AU 2003203233A1
Authority
AU
Australia
Prior art keywords
preventive
same
therapeutic drugs
sulfonamide derivatives
substituted sulfonamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003203233A
Inventor
Teruo Shiomi
Toshisada Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2003203233A1 publication Critical patent/AU2003203233A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/27—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003203233A 2002-01-17 2003-01-16 N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same Abandoned AU2003203233A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-8302 2002-01-17
JP2002008302 2002-01-17
PCT/JP2003/000315 WO2003059870A1 (en) 2002-01-17 2003-01-16 N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same

Publications (1)

Publication Number Publication Date
AU2003203233A1 true AU2003203233A1 (en) 2003-07-30

Family

ID=19191410

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003203233A Abandoned AU2003203233A1 (en) 2002-01-17 2003-01-16 N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same

Country Status (3)

Country Link
JP (1) JPWO2003059870A1 (en)
AU (1) AU2003203233A1 (en)
WO (1) WO2003059870A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
JP4904026B2 (en) * 2004-08-04 2012-03-28 日本曹達株式会社 Novel compound for forming photoreactive organic thin film and organic thin film forming body
DE102008019838A1 (en) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh New arylsulfonylglycine derivatives, their preparation and their use as pharmaceuticals
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN113388007A (en) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 Ultra-pure agonists of guanylate cyclase C, methods of making and using the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001024786A1 (en) * 1999-05-13 2001-04-12 Shionogi & Co., Ltd. Preventive or therapeutic drugs for diabetes

Also Published As

Publication number Publication date
WO2003059870A1 (en) 2003-07-24
JPWO2003059870A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
IL163866A0 (en) 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient
PL372865A1 (en) Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same
AU4612300A (en) Preventive or therapeutic drugs for diabetes
EP1389621A4 (en) N-substituted pyrazolyl-o-glycoside derivatives and remedial agent for diabetes containing the same
AU2003298841A1 (en) Pharmaceutical compositions containing indistinguishable drug components
IL202190A0 (en) Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
PL375790A1 (en) Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2003288994A1 (en) Nitrogen-containing heterocyclic compounds and medicinal use thereof
IL163117A (en) Indazole derivatives and pharmaceutical compositions containing the same
IL164455A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
AU2003254950A1 (en) Peptides and drugs containing the same
EP1587474A3 (en) Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
IL191960A0 (en) Heterocyclic aromatic compounds and pharmaceutical compositions containing the same
EP1557415A4 (en) Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
IL157740A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003295890A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AU2003243439A1 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU2003262230A1 (en) Preventive and/or therapeutic drugs for itch
AU2003262229A1 (en) Preventive and/or therapeutic drugs for asthma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase